1. Home
  2. Vincaleukoblastine, sulfate (1:1) (salt)

Contact Angene

Tel: +852 8191 6999

Email: [email protected]

Brc1cnc(nc1)C
Pyrimidine, 5-bromo-2-methyl-
CCCP1(=O)OP(=O)(CCC)OP(=O)(O1)CCC
1,3,5,2,4,6-Trioxatriphosphorinane, 2,4,6-tripropyl-, 2,4,6-trioxide
CC1(C)OB(OC1(C)C)B1OC(C(O1)(C)C)(C)C
2,2'-Bi-1,3,2-dioxaborolane, 4,4,4',4',5,5,5',5'-octamethyl-
O=C(C=Cc1ccccc1)C=Cc1ccccc1.O=C(C=Cc1ccccc1)C=Cc1ccccc1.O=C(C=Cc1ccccc1)C=Cc1ccccc1.[Pd].[Pd]
Tris(dibenzylideneacetone)dipalladium
C1CCC(CC1)P(C1CCCCC1)C1CCCCC1.Cc1cc(C)c(c(c1)C)N1CCN(C1=[Ru](=Cc1ccccc1)(Cl)Cl)c1c(C)cc(cc1C)C
Ruthenium,[1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro(phenylmethylene)(tricyclohexylphosphine)-, (SP-5-41)-

Vincaleukoblastine, sulfate (1:1) (salt)

OS(=O)(=O)O.COc1cc2N(C)[C@@H]3[C@@]4(c2cc1[C@]1(CC2CN(CCc5c1[nH]c1c5cccc1)C[C@](C2)(O)CC)C(=O)OC)CCN1[C@H]4[C@@]([C@H]([C@]3(O)C(=O)OC)OC(=O)C)(CC)C=CC1 Request for Quotation
Chemical Name: Vincaleukoblastine, sulfate (1:1) (salt)
CAS Number: 143-67-9
Product Number: AG003AJN(AGN-PC-0PUEHX)
Synonyms:
MDL No:
Molecular Formula: C46H60N4O13S
Molecular Weight: 909.0526

Identification/Properties

Computed Properties
Molecular Weight:
909.061g/mol
Hydrogen Bond Donor Count:
5
Hydrogen Bond Acceptor Count:
16
Rotatable Bond Count:
10
Exact Mass:
908.388g/mol
Monoisotopic Mass:
908.388g/mol
Topological Polar Surface Area:
237A^2
Heavy Atom Count:
64
Formal Charge:
0
Complexity:
1780
Isotope Atom Count:
0
Defined Atom Stereocenter Count:
9
Undefined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Covalently-Bonded Unit Count:
2
Compound Is Canonicalized:
Yes

Safety Information

NMR Spectrum

Other Analytical Data

Request for Quotation

Customer Feedback

Chemical Structure


Vincaleukoblastine sulfate (1:1) is commonly utilized in chemical synthesis as a potent antineoplastic agent. Its ability to interfere with microtubule assembly and disrupt normal cellular processes makes it a valuable tool in the development of cancer-fighting drugs. Through targeted interactions with tubulin, vincaleukoblastine sulfate inhibits cell division and induces apoptosis in cancer cells, thereby suppressing tumor growth. This compound plays a crucial role in the synthesis of novel pharmaceuticals aimed at combating various forms of cancer by exploiting its unique mechanisms of action in disrupting mitosis and promoting cell death.